Bokf, Na Abb Vie Inc. Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

A detailed history of Bokf, Na transactions in Abb Vie Inc. stock. As of the latest transaction made, Bokf, Na holds 268,606 shares of ABBV stock, worth $47.5 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

268,606

Previous 264,930 1.39%

Holding current value

$47.5 Million

Previous $45.4 Million 16.73%

% of portfolio

0.94%

Previous 0.82%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $602,275 - $732,737	3,676 Added 1.39%	268,606 $53 Million
Q2 2024 Aug 07, 2024	BUY	$154.79 - $180.76 $774,414 - $904,342	5,003 Added 1.92%	264,930 $45.4 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $9.5 Million - $10.8 Million	-59,413 Reduced 18.6%	259,927 $47.3 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $2.15 Million - $2.42 Million	15,642 Added 5.15%	319,340 $49.5 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $1.51 Million - $1.74 Million	-11,274 Reduced 3.58%	303,698 $45.3 Million
Q2 2023 Aug 21, 2023	SELL	$132.51 - $164.9 $2.13 Million - $2.65 Million	-16,086 Reduced 4.86%	314,972 $42.4 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $6.2 Million - $7.14 Million	-42,893 Reduced 11.47%	331,058 $52.8 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $884,630 - $1.06 Million	-6,396 Reduced 1.68%	373,951 $60.5 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $3.88 Million - $4.45 Million	-28,913 Reduced 7.06%	380,347 $51 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $585,848 - $744,804	-4,257 Reduced 1.03%	409,260 $62.7 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $401,219 - $497,800	-3,040 Reduced 0.73%	413,517 $67 Million
Q4 2021 Mar 11, 2022	SELL	$107.43 - $135.93 $28.2 Million - $35.6 Million	-262,156 Reduced 38.63%	416,557 $56.4 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $48.6 Million - $55.2 Million	-457,090 Reduced 40.24%	678,713 $73.2 Million
Q1 2021 Apr 21, 2021	BUY	$102.3 - $112.62 $1.49 Million - $1.64 Million	14,544 Added 1.3%	1,135,803 $123 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $65.2 Million - $88 Million	809,846 Added 260.06%	1,121,259 $120 Million
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $3.48 Million - $4.09 Million	40,559 Added 14.97%	311,413 $27.3 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $4.39 Million - $5.87 Million	59,786 Added 28.33%	270,854 $26.6 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $3.17 Million - $4.81 Million	49,138 Added 30.35%	211,068 $16.1 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $17,743 - $22,201	246 Added 0.15%	161,930 $14.3 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $1.03 Million - $1.23 Million	16,280 Added 11.2%	161,684 $12.2 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $880,511 - $1.13 Million	13,402 Added 10.15%	145,404 $10.6 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $6.44 Million - $7.58 Million	-83,454 Reduced 38.73%	132,002 $10.6 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $1.34 Million - $1.65 Million	17,226 Added 8.69%	215,456 $19.9 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $1.55 Million - $1.72 Million	17,398 Added 9.62%	198,230 $18.7 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $5 Million - $5.91 Million	55,672 Added 44.48%	180,832 $16.8 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $367,303 - $491,854	-3,992 Reduced 3.09%	125,160 $11.8 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $607,306 - $665,962	-6,781 Reduced 4.99%	129,152 $12.5 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $9.49 Million - $12.1 Million	135,933	135,933 $12.1 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account